Comparison Between LDCT With DL Recontruction and Standard Dose CT
NCT05324046 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 134
Last updated 2023-08-18
Summary
This prospective study aims to perform intra-individual comparison of the image quality between low dose liver CT with deep learning reconstruction and standard dose liver CT with iterative reconstruction in patients with liver metastasis.
Conditions
- Liver Metastases
Interventions
- DIAGNOSTIC_TEST
-
contrast-enhanced abdomen CT
contrast-enhanced abdomen CT using dual-source CT scanner using A-tube (67% radiation) and B-tube (33% radiation). * full dose CT data (A +B tubes, 100%) are reconstructed with iterative reconstruction (conventional) * low dose CT data (A-tube only, B-tube only) are reconstructed with deep learning commercially available software. * images are reconstructed using full dose (A- \& B- tubes) and smaller dose (A-tube only, B-tube only)
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Jeong Min Lee, MD · Seoul National University Hospital
Eligibility
- Min Age
- 20 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-02
- Primary Completion
- 2023-12-30
- Completion
- 2024-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
"Double Low-Dose" DECT for HCC Imaging
NCT03045445 ·Status: COMPLETED ·Phase: NA
-
Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma
NCT07030842 ·Status: COMPLETED
-
LEAF(Liver Tumor dEtection And classiFication AI)
NCT06859840 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB
NCT06616103 ·Status: NOT_YET_RECRUITING
-
The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions
NCT07055048 ·Status: NOT_YET_RECRUITING
-
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
NCT06537193 ·Status: RECRUITING ·Phase: NA
-
Radiomics for Diagnosing Liver Diseases and Evaluating Progression
NCT03221049 ·Status: UNKNOWN
-
Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance
NCT02854241 ·Status: UNKNOWN ·Phase: NA
-
Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE
NCT03731910 ·Status: UNKNOWN ·Phase: NA
-
Ga-68 Dolacga PET Scan in HCC Under RFA
NCT06792097 ·Status: NOT_YET_RECRUITING
-
A Prospective Study of ¹⁸F-DFA PET Imaging for the Assessment of Liver Injury
NCT07050550 ·Status: RECRUITING
-
Non-contrast Abbreviated MRI for Secondary Surveillance of HCC
NCT05690451 ·Status: COMPLETED
-
Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of CEUS and CEMRI Versus CECT and CEMRI
NCT03267290 ·Status: COMPLETED ·Phase: NA
-
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma
NCT03198975 ·Status: UNKNOWN
-
Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .
NCT06168357 ·Status: NOT_YET_RECRUITING
-
Identification of Hepatic Lesions
NCT00307866 ·Status: COMPLETED ·Phase: PHASE3
-
The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment
NCT04299919 ·Status: UNKNOWN
-
Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver
NCT01501240 ·Status: WITHDRAWN
-
Different Abbreviated MRI for Hepatocellular Carcinoma Diagnosis
NCT06663904 ·Status: COMPLETED
-
Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)
NCT07059936 ·Status: RECRUITING
-
Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS
NCT06590948 ·Status: RECRUITING
-
Role of CEUS as a Secondary Diagnostic Modality
NCT04494022 ·Status: UNKNOWN ·Phase: NA
-
Development of a Set of Auxiliary Decision-making System for the Perioperative Period of Hepatectomy Based on Static CT and Artificial Intelligence.
NCT07056270 ·Status: NOT_YET_RECRUITING
-
Automatic Segmentation of Polycystic Liver
NCT03960710 ·Status: UNKNOWN
-
Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC)
NCT05543304 ·Status: UNKNOWN